Lee Kaplan, MD
Gastroenterology · Lebanon, NHNPI 1255322475
Payments from drug & device makers
Across 497 payments — averaging $2437.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$524K
- Novo Nordisk AS$201K
- Pfizer$119K
- Eli Lilly$92K
- Boehringer Ingelheim International GmbH$91K
- Boehringer Ingelheim$83K
- plus $102K from 16 others
Across 2 payments — averaging $9488.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$11K
- Boehringer Ingelheim International GmbH$8K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 104 | $523,775 |
| Novo Nordisk AS | 35 | $200,502 |
| Pfizer | 17 | $119,133 |
| Eli Lilly | 109 | $91,845 |
| Boehringer Ingelheim International GmbH | 71 | $91,162 |
| Boehringer Ingelheim | 73 | $82,587 |
| Novo Nordisk Health Care AG | 3 | $21,174 |
| Medical Device Business Services, Inc. | 27 | $18,993 |
| Amgen | 7 | $15,981 |
| Perspectum Diagnostics Ltd | 1 | $14,558 |
| AstraZeneca | 9 | $9,154 |
| Rhythm Pharmaceuticals, Inc. | 3 | $6,303 |
| Boehringer Ingelheim Espana S.A. | 2 | $6,124 |
| Genentech USA, Inc. | 3 | $3,448 |
| Gilead | 2 | $3,061 |
| Lilly USA, LLC | 22 | $2,017 |
| Johnson & Johnson Medical Devices & Diagnostics Group - Latin America, L.L.C. | 2 | $693 |
| Johnson & Johnson(2 entities) | 2 | $244 |
| Covidien LP | 2 | $189 |
| Madrigal Pharmaceuticals | 1 | $141 |
| Astrazeneca UK Limited | 1 | $135 |
| Baxter Healthcare | 1 | $40 |
How this compares
$1,211,258 in reported general payments places this provider in the 95th percentile of 91 gastroenterology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Lebanon
- Corey SiegelLebanon$1.9M
- Brian LacyLebanon$550K
- Michael CurleyLebanon$231K
- Shelby SullivanLebanon$153K
- Arifa ToorLebanon$121K
- Liam ZakkoLebanon$117K
- Stuart GordonLebanon$93K
- Michael WinterLebanon$58K
- Timothy GardnerLebanon$17K
- Audrey CalderwoodLebanon$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.